ALBO - Albireo Pharma Inc
Close
44.15
-0.100 -0.227%
Share volume: 1,241,282
Last Updated: Thu 02 Mar 2023 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$44.25
-0.10
-0.23%
Summary score
11%
Profitability
0%
Dept financing
14%
Liquidity
51%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2018 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-18.05%
Return on assets
-10.81%
Return on sales
-1147.33%
Return on invested capital
-433.78%
Total debt ratio
42.44%
Debt ratio change over timeo
-1.13%
Current Ratio
9.7%
Quick Ratio
9.68%
Cash Position Ratio
9.29%
Short-term ratios 30-Sep-2021 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.95%
Return on assets
-10.54%
Return on sales
-325.43%
Return on invested capital
-935.06%
Total debt ratio
51.09%
Debt ratio change over timeo
-1.06%
Current Ratio
6%
Quick Ratio
5.95%
Cash Position Ratio
5.6%
Last quarter ratios 30-Sep-2022
The data are presented for the financials results of the last quarter.
Return on equity
-37.77%
Return on assets
-10.79%
Return on sales
-352.48%
Return on invested capital
-84.82%
Total debt ratio
68.85%
Debt ratio change over time
-1.81%
Current Ratio
6.32%
Quick Ratio
6.23%
Cash Position Ratio
5.88%
Performance ratios (change over 4 years) 30-Sep-2018 - 30-Sep-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-93.97%
Return on assets
-96.66%
Return on sales
335.32%
Return on invested capital
-222.61%
Total debt ratio
-112.65%
Debt ratio change over time
-1.13%
Current Ratio
-4.44%
Quick Ratio
-4.43%
Cash Position Ratio
-4.32%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALBO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -18.05% | 0% | 0% | -98.68% |
| Return on assets | -10.81% | 0% | 0% | -10.36% |
| Return on sales | -1147.33% | 0% | 0% | -4130.66% |
| Return on invested capital | -433.78% | 0% | 0% | 39.41% |
| Profitability | 0% | 0% | 75% | 25% |
| Total debt ratio | 42.44% | 0% | 0% | 79.45% |
| Debt ratio change over time | -1.13% | 0% | 0% | -0.34% |
| Dept financing | 13% | 0% | 25% | 25% |
| Current Ratio | 6% | 0% | 0% | 10.69% |
| Quick Ratio | 5.95% | 0% | 0% | 10.69% |
| Cash Position Ratio | 5.6% | 0% | 0% | 10.53% |
| Liquididy | 75% | 0% | 0% | 59% |
| Short-term ratios | ALBO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -26.95% | 0% | 0% | -490.06% |
| Return on assets | -10.54% | 0% | 0% | -10.34% |
| Return on sales | -325.43% | 0% | 0% | -9029.8% |
| Return on invested capital | -935.06% | 0% | 0% | -85.96% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 51.09% | 0% | 0% | 86.06% |
| Debt ratio change over time | -1.06% | 0% | 0% | -2.02% |
| Dept financing | 15% | 0% | 25% | 25% |
| Current Ratio | 6% | 0% | 0% | 10.69% |
| Quick Ratio | 5.95% | 0% | 0% | 10.69% |
| Cash Position Ratio | 5.6% | 0% | 0% | 10.53% |
| Liquididy | 41% | 0% | 0% | 75% |